CENGİZ SEVAL, G. Et Al. 2020. Flamsa-based High-dose Sequential Conditioning Regimen followed by Allogeneic Hematopoietic Stem Cell Transplantation(ALLO-HSCT): Is It Effective in Patients with Primary Refractory or Relapsed Acute Leukemia?. BONE MARROW TRANSPLANTATION , vol.55, no.SUPPL 1 , 305-306.

CENGİZ SEVAL, G., Kircali, E., CİVRİZ BOZDAĞ, S., TOPRAK, S. K., Yuksel, M. K., ARSLAN, Ö., ... ÖZCAN, M.(2020). Flamsa-based High-dose Sequential Conditioning Regimen followed by Allogeneic Hematopoietic Stem Cell Transplantation(ALLO-HSCT): Is It Effective in Patients with Primary Refractory or Relapsed Acute Leukemia?. BONE MARROW TRANSPLANTATION , vol.55, no.SUPPL 1, 305-306.

CENGİZ SEVAL, GÜLDANE Et Al. "Flamsa-based High-dose Sequential Conditioning Regimen followed by Allogeneic Hematopoietic Stem Cell Transplantation(ALLO-HSCT): Is It Effective in Patients with Primary Refractory or Relapsed Acute Leukemia?," BONE MARROW TRANSPLANTATION , vol.55, no.SUPPL 1, 305-306, 2020

CENGİZ SEVAL, GÜLDANE C. Et Al. "Flamsa-based High-dose Sequential Conditioning Regimen followed by Allogeneic Hematopoietic Stem Cell Transplantation(ALLO-HSCT): Is It Effective in Patients with Primary Refractory or Relapsed Acute Leukemia?." BONE MARROW TRANSPLANTATION , vol.55, no.SUPPL 1, pp.305-306, 2020

CENGİZ SEVAL, G. Et Al. (2020) . "Flamsa-based High-dose Sequential Conditioning Regimen followed by Allogeneic Hematopoietic Stem Cell Transplantation(ALLO-HSCT): Is It Effective in Patients with Primary Refractory or Relapsed Acute Leukemia?." BONE MARROW TRANSPLANTATION , vol.55, no.SUPPL 1, pp.305-306.

@article{article, author={GÜLDANE CENGİZ SEVAL Et Al. }, title={Flamsa-based High-dose Sequential Conditioning Regimen followed by Allogeneic Hematopoietic Stem Cell Transplantation(ALLO-HSCT): Is It Effective in Patients with Primary Refractory or Relapsed Acute Leukemia?}, journal={BONE MARROW TRANSPLANTATION}, year=2020, pages={305-306} }